Cures Acceleration Network Review Board Roster
| Chairperson Freda C. Lewis-Hall, M.D. (2015) Chief Medical Officer Pfizer New York, N.Y. Vice Chairperson Geoffrey S. Ginsburg, M.D., Ph.D. (2016) Director of Genomic Medicine Institute for Genome Sciences and Policy Executive Director, Center for Personalized Medicine Duke University Health System Professor of Medicine and Pathology Duke University School of Medicine Durham, N.C. | Executive Secretary Danilo A. Tagle, M.S., Ph.D. Acting Director Office of Grants Management and Scientific Review National Center for Advancing Translational Sciences National Institutes of Health Bethesda, Md. |
Board Members
(Terms end 9/30 of designated year.)
| Margaret A. Anderson, M.A. (2014) Executive Director FasterCures Center for Accelerating Medical Solutions Washington, D.C. Robert J. Beall, Ph.D. (2016) President and CEO Cystic Fibrosis Foundation Bethesda, Md. R. Alta Charo, J.D. (2016) Warren P. Knowles Professor of Law & Bioethics University of Wisconsin Law School and School of Medicine & Public Health Madison, Wis. Jorge L. Contreras, J.D. (2014) Associate Professor Washington College of Law American University Washington, D.C. Pamela B. Davis, M.D., Ph.D. (2015) Dean and Vice President for Medical Affairs Office of the Dean Case Western Reserve University Cleveland, Ohio Louis J. DeGennaro, Ph.D. (2014) Chief Mission Officer Leukemia & Lymphoma Society White Plains, N.Y. Mary L. Disis, M.D. (2015) Professor, Department of Medicine Division of Oncology University of Washington School of Medicine Seattle, Wash. Frank L. Douglas, Ph.D., M.D. (2016) President and CEO Austen BioInnovation Institute in Akron Akron, Ohio Victoria G. Hale, Ph.D. (2015) CEO and Founder Medicines360 San Francisco, Calif. | Eric D. Kodish, M.D. (2014) F.J. O'Neill Professor and Chairman Department of Bioethics Cleveland Clinic Foundation Cleveland, Ohio Bernard H. Munos, M.B.A. (2016) Founder InnoThink Center for Research in Biomedical Innovation Indianapolis, Ind. Franklyn G. Prendergast, M.D., Ph.D. (2014) Professor of Pharmacology and of Molecular Pharmacology and Experimental Therapeutics Mayo Medical School Rochester, Minn. Todd B. Sherer, Ph.D. (2015) CEO Michael J. Fox Foundation for Parkinson's Research New York, N.Y. Lawrence A. Soler, J.D. (2015) President and CEO Partnership for a Healthier America Washington, D.C. Myrl Weinberg, M.A. (2015) President National Health Council, Inc. Washington, D.C. Scott J. Weir, Pharm.D., Ph.D. (2016) Director Institute for Advancing Medical Innovation University of Kansas Cancer Center Kansas City, Kan. Paul G. Yock, M.D. (2014) Martha Meier Weiland Professor Departments of Bioengineering and Medicine, Program in Biodesign Stanford University Stanford, Calif. |
Representative Members
| Ankit A. Mahadevia, M.D., M.B.A. (2016) Principal Atlas Venture Cambridge, Mass. Susan E. Siegel, M.S. (2014) CEO Healthymagination General Electric Co. Menlo Park, Calif. | Robert I. Tepper, M.D. (2016) Partner Third Rock Ventures, LLC Boston, Mass. Tadataka Yamada, M.D. (2014) Chief Medical and Scientific Officer Executive Vice President Takeda Pharmaceuticals International Seattle, Wash. |
Ex Officio Members
| Office of the Secretary, DHHS Kathleen Sebelius Secretary Department of Health and Human Services Washington, D.C. Food and Drug Administration Margaret A. Hamburg, M.D. Commissioner Silver Spring, Md. National Science Foundation Susanne Hambrusch, Ph.D. Director Division of Computing and Communication Foundations Directorate for Computer & Information Science & Engineering Arlington, Va. | National Institutes of Health Francis S. Collins, M.D., Ph.D. Director Bethesda, Md. Department of Defense Larry Sipos, M.B.A. Acting Deputy Assistant Secretary of Defense for Force Health Protection & Readiness Falls Church, Va. Department of Veterans Affairs Joel Kupersmith, M.D. Chief Research and Development Officer Washington, D.C. |
Social Media Links